Pharmaceutical drug development
Pharmaceuticals
At SCRO, we are passionate about helping pharmaceutical companies and researchers move forward in their clinical drug development.
Expert support in pharmaceutical drug development
From start-to-finish, we have experience in designing and conducting Phase I to IV clinical trials and non-interventional studies (NIS) in compliance with GCP and other regulatory guidelines. SCRO has successfully helped clients worldwide with pharmaceutical drug development in a wide range of therapeutic areas including cardiology, oncology, urology, CNS, endocrinology, HIV, gastroenterology, anaesthesia, and more.
SCRO services within pharmaceutical drug development
Phase I to Phase III clinical trials
From first-in-human studies to pivotal trials, SCRO has proven expertise with designing and conducting Phase I to Phase III clinical trials in a wide range of therapeutic areas. SCRO has the know-how to support you during all phases of clinical trials for pharmaceuticals and biologics, ensuring that your study delivers high-quality results and follows regulatory guidelines, budget, and timelines.
Post-marketing studies
Post-marketing studies are vital for continuing to monitor the safety, efficacy and optimal use of marketed drugs and biologics. Let SCRO support you in planning and carrying out post-marketing studies that gather real world clinical data to assess your biologic or drug product’s safety and efficacy profile.
Investigator sponsored studies
Are you a doctor or academic researcher in need of the right support to start a clinical trial? Whether you need additional study personnel such as a research nurse or you require help from start to finish, SCRO can help you translate your idea within pharmaceutical drug development to the clinic where you can ultimately impact the health of future patients.